trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Diffuse slowing in EEG is a clinical indicator associated with Alzheimer's disease

the verdict
SUPPORTED
the evidence backs this
Recorded sources
6 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that diffuse slowing in EEG is a clinical indicator associated with Alzheimer's disease?

Yes. Multiple studies demonstrate that diffuse EEG slowing—specifically characterized by increased delta and theta activity alongside reduced alpha power—is a well-documented electrophysiological indicator associated with Alzheimer's disease.

Verdict: SUPPORTED · 6 sources for, 0 against · Last checked

The analysis

The provided literature consistently points to EEG spectral slowing (elevated delta/theta power and reduced alpha power or frequency) as a hallmark signature of Alzheimer's disease. All relevant sources that address EEG features in Alzheimer's patients support this association, and no papers refute it.

Evidence for · 6
Quantitative Electroencephalography Power and Coherence in Alzheimer's Disease and Mild Cognitive Impairment
1996
Identifies significantly increased theta and decreased alpha relative power as distinguishing features of Alzheimer's disease.
Get citation
Jelic, V., Shigeta, M., Julin, P., Almkvist, O., Winblad, B., & Wahlund, L. (1996). Quantitative Electroencephalography Power and Coherence in Alzheimer's Disease and Mild Cognitive Impairment. doi.org. https://doi.org/10.1159/000106897

See more details
More for · 5
A deep-SVM hybrid framework with enhanced EEG feature engineering and SHAP-based explainability for Alzheimer's classification.
2026
Utilizes spectral biomarkers including elevated theta and altered alpha coherence to successfully classify Alzheimer's disease from controls.
Get citation
F, A., Y, A., SM, U., S, K., I, I., & MA, A. (2026). A deep-SVM hybrid framework with enhanced EEG feature engineering and SHAP-based explainability for Alzheimer's classification.. doi.org. https://doi.org/10.1038/s41598-026-43431-w

EEG network reorganization across Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies.
2026
Notes that spectral slowing, characterized by delta and theta increases and posterior alpha loss, is well documented in Alzheimer's disease.
Get citation
A, B., V, C., F, P., D, A., DV, M., P, M., & B, B. (2026). EEG network reorganization across Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies.. doi.org. https://doi.org/10.1002/dad2.70275

Resting-State EEG captures functional network correlates of plasma p-Tau-217 in Alzheimer's disease.
2026
Finds that Alzheimer's patients exhibit spectral slowing such as higher theta and lower alpha power.
Get citation
G, C., J, L., L, Z., G, R., S, B., M, C., F, C., EG, S., A, G., E, C., E, S., F, C., R, S., D, C., GF, F., A, B., G, M., F, A., & M, F. (2026). Resting-State EEG captures functional network correlates of plasma p-Tau-217 in Alzheimer's disease.. doi.org. https://doi.org/10.1016/j.nicl.2026.103947

From brain waves to heartbeats: Exploring the combined role of electroencephalography and heart-rate variability in Alzheimer's disease diagnosis and management.
2026
Highlights that electroencephalography reveals patterns of cortical slowing and desynchronization in Alzheimer's disease.
Get citation
BOA, B., I, K., A, K., S, P., S, G., S, B., A, H., G, L., A, A., Y, C., MI, P., A, J., & N, N. (2026). From brain waves to heartbeats: Exploring the combined role of electroencephalography and heart-rate variability in Alzheimer's disease diagnosis and management.. doi.org. https://doi.org/10.1177/13872877261428636

A Two-Stage EEG Microstate Fusion Framework for Dementia Screening and Alzheimer's Disease/Frontotemporal Dementia Differentiation.
2026
Employs delta and theta dynamics in a hierarchical deep learning framework to effectively differentiate and screen for Alzheimer's disease.
Get citation
L, J., Y, C., Y, H., J, L., X, Z., & X, G. (2026). A Two-Stage EEG Microstate Fusion Framework for Dementia Screening and Alzheimer's Disease/Frontotemporal Dementia Differentiation.. doi.org. https://doi.org/10.3390/bios16050258

Related receipts

What does the evidence say?

The provided literature consistently points to EEG spectral slowing (elevated delta/theta power and reduced alpha power or frequency) as a hallmark signature of Alzheimer's disease. All relevant sources that address EEG features in Alzheimer's patients support this association, and no papers refute it.

Receipt History
first checked04 Aug 2026
judged → SUPPORTED · 8504 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work